UGOLINI, Alessio
 Distribuzione geografica
Continente #
EU - Europa 299
NA - Nord America 282
AS - Asia 193
AF - Africa 5
Totale 779
Nazione #
US - Stati Uniti d'America 276
IT - Italia 187
CN - Cina 61
SG - Singapore 48
SE - Svezia 32
IN - India 26
MO - Macao, regione amministrativa speciale della Cina 21
HK - Hong Kong 14
FI - Finlandia 9
FR - Francia 9
GB - Regno Unito 9
ID - Indonesia 8
PL - Polonia 8
DE - Germania 7
BG - Bulgaria 6
CA - Canada 6
UA - Ucraina 5
CH - Svizzera 4
JP - Giappone 4
NL - Olanda 4
PT - Portogallo 4
DK - Danimarca 3
IR - Iran 3
MA - Marocco 3
RU - Federazione Russa 3
BE - Belgio 2
KZ - Kazakistan 2
RO - Romania 2
TG - Togo 2
AM - Armenia 1
AT - Austria 1
BY - Bielorussia 1
ES - Italia 1
GE - Georgia 1
IE - Irlanda 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
TH - Thailandia 1
TR - Turchia 1
Totale 779
Città #
Rome 88
Singapore 31
Chandler 27
Fairfield 27
Macao 21
Milan 18
Ashburn 15
Cambridge 14
Philadelphia 14
San Paolo di Civitate 14
Seattle 14
Houston 12
Wilmington 12
Helsinki 9
Princeton 9
Jakarta 8
Lawrence 8
New York 8
Santa Clara 8
Hong Kong 7
Sofia 6
Woodbridge 6
Zamienie 6
Hangzhou 5
Millbury 5
San Diego 5
Shanghai 5
Ann Arbor 4
Austin 4
Beijing 4
Bologna 4
Boston 4
Cagliari 4
Congleton 4
Minatomirai 4
Montreal 4
Renens 4
Wuhan 4
Avellino 3
Chicago 3
Chiesina Uzzanese 3
Guangzhou 3
Latina 3
Marrakesh 3
Moscow 3
Redwood City 3
Stockholm 3
Winston-Salem 3
Albano Laziale 2
Bengaluru 2
Boardman 2
Bremen 2
Brindisi 2
Brunoy 2
Brussels 2
Cascina 2
Chions 2
Dallas 2
Hojslev 2
Huizhou 2
Hyderabad 2
Kumar 2
Ladispoli 2
Lisbon 2
Livorno 2
Lomé 2
London 2
Madison 2
Mannheim 2
Norwalk 2
Omaha 2
Pathanamthitta 2
Reggio Calabria 2
Ridder 2
Trieste 2
Vaas 2
Zhongshan 2
Andover 1
Assisi 1
Bangkok 1
Berkeley 1
Bishkek 1
Brighton 1
Carate Brianza 1
Central 1
Centro 1
Changsha 1
Chaozhou 1
Cincinnati 1
Dublin 1
Falkenstein 1
Foshan 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Istanbul 1
Kish 1
Locorotondo 1
Montelabbate 1
Mumbai 1
Totale 557
Nome #
Circulating CD137 + T cells correlate with improved response to anti-PD1 immunotherapy in cancer patients 156
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma 112
Probing neutrophils heterogeneity in Glioblastoma: how the metabolism shapes the function of immunosuppressive CD71+Neutrophils 72
null 64
Myeloid cells in glioblastoma microenvironment 62
Polymorphonuclear myeloid-derived suppressor cells limit antigen crosspresentation by dendritic cells in cancer 61
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137 + T-cells 55
IgM-rheumatoid factor as a novel biomarker for a reduced survival in anti-PD-1 treated NSCLC patients through the decrease of CD137+T-cells 48
null 45
Immunomodulatory effects of tyrosine kinase inhibitors (TKIs) in renal cell carcinoma (RCC) patients 42
Soluble Immune checkpoints, gut metabolites and performance status as parameters of response to Nivolumab treatment in NSCLC patients 34
null 29
DNA damage response and repair (DDR) gene mutations as an alternative mechanism to generate high TMB in never smoker NSCLC patients 24
Immunohistochemical characterization of immune infiltrate in tumor microenvironment of glioblastoma 14
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature 12
Soluble Immune Checkpoints, Gut Metabolites and Performance Status as Parameters of Response to Nivolumab Treatment in NSCLC Patients 11
Rheumatoid factor: a novel determiner in cancer history 8
Totale 849
Categoria #
all - tutte 3.135
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.135


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021132 0 0 11 4 51 8 10 13 13 1 7 14
2021/2022133 2 3 10 3 8 4 12 19 13 14 33 12
2022/2023184 25 29 15 11 14 19 12 22 9 14 7 7
2023/2024219 1 7 4 9 12 29 36 43 2 22 29 25
2024/2025181 24 23 40 32 22 40 0 0 0 0 0 0
Totale 849